Company Description
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide.
The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM).
It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures.
The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market.
It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories.
The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.
Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
| Country | United States |
| IPO Date | Jan 2, 2019 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 252 |
| CEO | Charles D. Goodwin II |
Contact Details
Address: 5115 Ulmerton Road Clearwater, Florida United States | |
| Website | https://www.apyxmedical.com |
Stock Details
| Ticker Symbol | APYX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000719135 |
| CUSIP Number | 03837C106 |
| ISIN Number | US03837C1062 |
| Employer ID | 11-2644611 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Charles D. Goodwin II | President, Chief Executive Officer & Director |
| Matthew C. Hill CPA | Chief Financial Officer, Treasurer & Secretary |
| Moshe Citronowicz | Senior Vice President |
| Stavros George Vizirgianakis B.Com. | Executive Chairman |
| Todd Hornsby | Executive Vice President |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 13, 2025 | 8-K | Current Report |
| Jan 06, 2025 | 8-K | Current Report |
| Nov 08, 2024 | 10-Q | Quarterly Report |
| Nov 08, 2024 | 424B5 | Filing |
| Nov 08, 2024 | 8-K | Current Report |
| Oct 31, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Oct 15, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2024 | 4 | Filing |
| Aug 12, 2024 | 4 | Filing |
| Aug 12, 2024 | 4 | Filing |